Hexagon Bio-Pharma Private Limited, a active private limited company, was established on 26 July 2006 in Bangalore, Karnataka, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24232KA2006PTC040046. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.20 Cr and a paid-up capital of ₹2.18 Cr.
It upholds a compliant status. Employing 27 professional, Its leadership includes Shashirekha Kolya (Director), Shridhar Punachithaya Kolya (Whole-Time Director). Past directors included Govardhan Krishna Shetty, Basheershekh Hussain, Manjunath Govindaiah. It holds ₹7.85 Cr open charges and ₹4.79 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.11-D Kiadb Industrial Area Doddaballapur, Bangalore, Karnataka, 561203.
U24232KA2006PTC040046
040046
26 July 2006
₹2.20 Cr
₹2.18 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Hexagon Bio-Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shashirekha Kolya | Director | 02 Nov 2023 | Current |
| Shridhar Punachithaya Kolya | Whole-Time Director | 02 Jul 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 19 Sep 2018 | Past |
| Pramod Abcsdd | Whole-Time Director | 19 Sep 2018 | Past |
| Pramod Abcsdd | Director | 07 Oct 2020 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 26 Oct 2023 | Past |
| Pramod Abcsdd | Director | 23 Jul 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hexagon Bio-Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.22% increase. The company also saw a substantial improvement in profitability, with a 125.15% increase in profit. The company's net worth Soared by an impressive increase of 68.13%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Hexagon Bio-Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹78,522,008.00
₹47,925,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Nov 2024 | Others | ₹4.32 Cr | Open |
| 24 Jan 2024 | Tata Capital Housing Finance Limited | ₹3.46 Cr | Open |
| 29 Aug 2008 | Vijaya Bank | ₹0.68 M | Open |
| 19 Jan 2021 | Others | ₹3.00 Cr | Satisfied |
| 24 Mar 2007 | Others | ₹1.79 Cr | Satisfied |
Explore comprehensive loan charge details -
Hexagon Bio-Pharma has a workforce of 27 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Hexagon Bio-Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hexagon Bio-Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 4.32 Cr with Charge ID 101008925 was registered on 19 Nov 2024. was recorded as a recent event.
The activity Hexagon Bio-Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Hexagon Bio-Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.
A charge registered on 19 Jan 2021 via Charge ID 100456219 with Others was fully satisfied on 07 Feb 2024. was recorded as a recent event.
The activity A charge with Tata Capital Housing Finance Limited amounted to Rs. 3.46 Cr with Charge ID 100859016 was registered on 24 Jan 2024. was completed.
The activity Shashirekha Kolya was appointed as a Director was appointed as a Director on 02 Nov 2023 & has been associated with this company since 2 years 2 months . was completed.
The CIN of Hexagon Bio-Pharma Private Limited is U24232KA2006PTC040046.
Hexagon Bio-Pharma Private Limited is headquartered at Plot No.11-D Kiadb Industrial Area Doddaballapur, Bangalore, Karnataka, 561203.
Hexagon Bio-Pharma Private Limited was incorporated on 26 July 2006.
The current directors of Hexagon Bio-Pharma Private Limited are
The primary industry of Hexagon Bio-Pharma Private Limited is Manufacturing.
Hexagon Bio-Pharma Private Limited is unlisted.
The authorized capital of Hexagon Bio-Pharma Private Limited is ₹2.20 Cr, and the paid-up capital is ₹2.18 Cr.
The compliance status of Hexagon Bio-Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX